The Zika Virus´s Immune Escape Strategy
– Important Insights for the Development of Antiviral Therapies A research team led by the Paul-Ehrlich-Institut examined the interaction between the Zika virus and the […]
institut
Paul-Ehrlich-Institut – Another Clinical Trial of a COVID-19 Vaccine authorised in Germany
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has authorised another clinical trial of a vaccine against COVID-19 in Germany. The intensive preliminary scientific advice […]
RECOVER – the Paul-Ehrlich-Institut Authorises another COVID-19 Therapy Study with Reconvalescent Plasma
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines has authorised the second clinical study with COVID-19 reconvalescent plasma (RECOVER) in Germany. The purpose of such […]
Warning against the Off label Use of BCG Products
In Germany, immunostimulatory products on the basis of bacteria preparations derived from the Bacillus Calmette-Guérin (BCG) mycobacterial strain are authorised for the treatment of urinary […]
Paul-Ehrlich Institut : First Clinical Trial of a COVID-19 Vaccine Authorised in Germany
The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, has authorised the first clinical trial of a vaccine against COVID-19 in Germany. Spike-Protein SARS-CoV-2 (Source: Viaframe/Corbis/GettyImages) […]
Fondation PSA provides exceptional support to “All United Against Coronavirus” alliance of Fondation de France, AP-HP and Institut Pasteur
• Mobilization for Covid-19 emergency aid, of all the funds allocated to the 2020 calls for projects of Fondation PSA • This donation will support […]